VIRILEX Trademark

Trademark Overview


On Wednesday, September 24, 2025, a trademark application was filed for VIRILEX with the United States Patent and Trademark Office. The USPTO has given the VIRILEX trademark a serial number of 99409726. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, January 31, 2026. The VIRILEX trademark is filed in the Pharmaceutical Products category with the following description:

Herbal male enhancement capsules
virilex

General Information


Serial Number99409726
Word MarkVIRILEX
Filing DateWednesday, September 24, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, January 31, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHerbal male enhancement capsules

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressSpring Grove, IL 60081

Trademark Events


Event DateEvent Description
Wednesday, September 24, 2025NEW APPLICATION ENTERED
Wednesday, September 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 24, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 30, 2026ASSIGNED TO EXAMINER
Saturday, January 31, 2026NON-FINAL ACTION WRITTEN
Saturday, January 31, 2026NON-FINAL ACTION E-MAILED
Saturday, January 31, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED